Cigna Healthcare Leads in Digital Experience Satisfaction for 2026

Explore how Cigna Healthcare is revolutionizing health management with top digital satisfaction scores according to JD Power's study, enhancing consumer experiences.

Expanding Ghana's NHIS for Modern Contraceptive Access

Ghana's NHIS expands contraceptive coverage, enhancing access and usage among women. Explore the impact on family planning and health equity.

College Retains 20% Employee Health Insurance Contribution Amid Rising Costs

College cancels plans to raise employee health insurance contributions, retaining 20% level amid rising healthcare costs affecting lower-wage staff.

Impact of Federal Policies on the U.S. Care Economy

Explore the impact of federal policies on the U.S. care economy, highlighting the role of insurers, venture capital, and caregiving challenges.

Virginia's House Bill 1214: Reducing Insulin Costs and Improving Accessibility

Virginia's House Bill 1214 cuts insulin costs and enhances access for diabetics; a critical move for health insurance reform and affordability.

Reshaping Healthcare: The Impact of the Affordable Care Act

Explore the impact of the Affordable Care Act on insurance and accessibility in healthcare, emphasizing reform and patient-centric care solutions.

Advocating High-Deductible Health Plans and HSAs: A Critical Analysis

Explore the efficacy and equity of high-deductible health plans and HSAs in U.S. healthcare, focusing on consumer empowerment and affordability.

Illinois Advances Abortion Access Fund Grant Program Legislation

Illinois advances the Abortion Access Fund Grant Program to improve healthcare access for the uninsured, addressing critical reproductive care needs.

Addressing Waste and Fraud in Government Health Programs

Join Brian Blase as he addresses waste, fraud, and improper payments in federal health programs at the National Press Club on April 28, featuring key speakers.

Impact of Generic Drugs and Biosimilars on Healthcare Costs

Explore the key impact of generic drugs and biosimilars on reducing prescription costs in the U.S. healthcare system, including legislative efforts and market dynamics.